Skip to main content
Patient-Centered Outcomes Research Institute
Patient-Centered Outcomes Research Institute
  • Blog
  • Newsroom
  • Find It Fast
  • Help Center
  • Subscribe
  • Careers
  • Contact Us

PCORI

Patient-Centered Outcomes Research Institute

Search form

  • About Us
    Close mega-menu

    About Us

    • Our Programs
    • Governance
    • Financials and Reports
    • Procurement Opportunities
    • Our Staff
    • Our Vision & Mission
    • Contact Us

    Fact Sheets: Learn More About PCORI

    Download fact sheets about out work, the research we fund, and our programs and initiatives.

    Find It Fast

    Browse through an alphabetical list of frequently accessed and searched terms for information and resources.

    Subscribe to PCORI Email Alerts

    Sign up for weekly emails to stay current on the latest results of our funded projects, and more.

  • Research & Results
    Close mega-menu

    Research & Results

    • Explore Our Portfolio
    • Research Fundamentals
    • Research Results Highlights
    • Putting Evidence to Work
    • Peer Review
    • Evidence Synthesis
    • About Our Research

    Evidence Updates from PCORI-Funded Studies

    These updates capture highlights of findings from systematic reviews and our funded research studies.

    Journal Articles About Our Funded Research

    Browse through a collection of journal publications that provides insights into PCORI-funded work.

    Explore Our Portfolio of Funded Projects

    Find out about projects based on the health conditions they focus on, the state they are in, and if they have results.

  • Topics
    Close mega-menu

    Topics

    • Addressing Disparities
    • Arthritis
    • Asthma
    • Cancer
    • Cardiovascular Disease
    • Children's Health
    • Community Health Workers
    • COVID-19
    • Dementia and Cognitive Impairment
    • Diabetes
    • Kidney Disease
    • Medicaid
    • Men's Health
    • Mental and Behavioral Health
    • Minority Mental Health
    • Multiple Chronic Conditions
    • Multiple Sclerosis
    • Obesity
    • Older Adults' Health
    • Pain Care and Opioids
    • Rare Diseases
    • Rural Health
    • Shared Decision Making
    • Telehealth
    • Transitional Care
    • Veterans Health
    • Women's Health

    Featured Topic: Women's Health

    Learn more about the projects we support on conditions that specifically or more often affect women.

  • Engagement
    Close mega-menu

    Engagement

    • The Value of Engagement
    • Engagement in Health Research Literature Explorer
    • Influencing the Culture of Research
    • Engagement Awards
    • Engagement Resources
    • Engage with Us

    Engagement Tools and Resources for Research

    This searchable peer-to-peer repository includes resources that can inform future work in patient-centered outcomes research.

    Explore Engagement in Health Literature

    This tool enables searching for published articles about engagement in health research.

    Research Fundamentals: A New On-Demand Training

    It enables those new to health research or patient-centered research to learn more about the research process.

  • Funding Opportunities
    Close mega-menu

    Funding Opportunities

    • What & Who We Fund
    • What You Need to Know to Apply
    • Applicant Training
    • Merit Review
    • Awardee Resources
    • Help Center

    PCORI Funding Opportunities

    View and learn about the newly opened funding announcements and the upcoming PFAs in 2021.

    Tips for Submitting a Responsive LOI

    Find out what PCORI looks for in a letter of intent (LOI) along with other helpful tips.

    PCORI Awardee Resources

    These resources can help awardees in complying with the terms and conditions of their contract.

  • Meetings & Events
    Close mega-menu

    Meetings & Events

    • Upcoming
    • Past Events

    PCORI Webinar: February 2, 2pm ET

    Hear from PCORI leaders about ways to get involved in PCOR, improvements to our funding opportunities, and more. Register

    Confronting COVID-19: A Webinar Series

    Learn more about the series and access recordings and summary reports of all six sessions.

    2020 PCORI Annual Meeting

    Watch recordings of all sessions, and view titles and descriptions of the posters presented at the virtual meeting.

You are here

  • Research & Results
  • Explore Our Portfolio
  • Comparing the Benefits and Harms of M...

Comparing the Benefits and Harms of Medicines for Long-Term Treatment of Blood Clots -- The ALTERNATIVE Study

Sign Up for Updates to This Study  

Project Summary  

PCORI has identified long-term use of blood thinner medicines as an important research topic. Blood thinners help prevent blood clots, but these medicines may cause other health problems if taken for a long time. Patients, clinicians, and others want to learn: How do different long-term blood thinner treatments compare for patients who have had a blood clot? To help answer this question, PCORI launched a funding initiative in 2015 on New Oral Anticoagulants (NOACs) in the Extended Treatment of Venous Thromboembolic Disease. This research project is one of the studies PCORI awarded as part of this program.

COVID-19-Related Project Enhancement

COVID-19 appears to affect blood clotting and may increase the risk of venous thromboembolism, or VTE. VTE occurs when blood clots develop inside veins. These blood clots can cause serious health problems or even death among patients in the hospital.

With this enhancement, the research team will compare the risk of VTE for patients in the hospital with and without COVID-19. The team will also look at how the risk of VTE may differ for certain groups of patients. These groups include older adults, men, patients who’ve had VTE before, and patients with severe COVID-19.

Enhancement Award Amount: $500,000

This research project is in progress. PCORI will post the research findings on this page within 90 days after the results are final.

What is the research about?

Each year, more than 500,000 people in the United States are hospitalized because of blood clots that form in their veins. Most blood clots form in people’s legs. But the clots can break loose and travel to the lungs, causing serious problems including death. More than 100,000 people in the United States die each year from blood clots that travel to their lungs.

For people who have had blood clots, blood thinners can prevent future blood clots. These medicines work well to prevent clots, but they may cause complications such as severe or uncontrolled bleeding.

Researchers don’t know whether some blood thinners work better than others to prevent future blood clots. They also don’t know whether some blood thinners are less likely than others to cause bleeding problems in people who take them for longer than three months. Few studies have looked at the use of blood thinners in people who are older, have kidney disease, or have had bleeding complications.

This study is looking at the benefits and risks of five blood thinners. The research team is comparing people who take these medicines for only three months with people who take these medicines for more than three months. The study is also comparing a blood thinner that has been available for a long time (warfarin) with four newer medicines: dabigatran, rivaroxaban, apixaban, and edoxaban. The research team is comparing the benefits and risks of the medicines for people with different characteristics.

Who can this research help?

This research can help people who need to take a blood thinner for more than three months. They and their doctors can use information from this study to help choose a medicine.

What is the research team doing?

The research team is looking at electronic health records for adults treated for a blood clot between 2010 and 2018 at Kaiser Permanente facilities in California. The patients have already taken blood-thinning medicine for at least three months. The research team is collecting information about patients’ health backgrounds, prescribed blood thinners, and changes in health. The team is asking people treated for a blood clot between 2015 and 2018 to take a survey. Questions ask about their health, well-being, and satisfaction with the treatment they received.

The researchers are looking at the number of blood clots each treatment prevented. They also are looking at the number of bleeding complications each treatment caused. The team is examining whether the risks and benefits differ for people with different characteristics, such as being older, having kidney disease, or having a high risk of bleeding. Patients who have had blood clots helped design the study and the survey.

Research methods at a glance

Design Element Description
Design Observational: cohort study
Population Adults who have had a blood clot and completed at least 3 months of treatment with blood thinners
Interventions/
Comparators
  • Warfarin
  • Dabitgatran
  • Rivaroxaban
  • Apixaban
  • Edoxaban
Outcomes Number of blood clots, number of bleeding complications
Timeframe Up to 10-year follow-up for study outcomes

Project Details

Principal Investigator
Margaret Fang, MD, MPH
Project Status
In progress; Recruitment not applicable
Project Title
The Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Extended Treatment of Venous Thromboembolism
Board Approval Date
July 2016
Project End Date
July 2022
Organization
University of California, San Francisco
Year Awarded
2016
State
California
Project Type
Research Project
Health Conditions  
Blood Disorders
Anemia
Cardiovascular Diseases
Deep Vein Thrombosis/Pulmonary Embolism
Kidney Diseases
Chronic Kidney Disease
Intervention Strategies
Drug Interventions
Populations
Individuals with Multiple Chronic/co-morbid Conditions
Older Adults
Funding Announcement
COVID-19-Related Project Enhancement
New Oral Anticoagulants (NOACs) in the Extended Treatment of Venous Thromboembolic Disease
Project Budget
$3,940,065
Study Registration Information
HSRP20164142
NCT03292666

Partners

Patient/Caregiver Partners

  • Mr. Randolph Fenninger; The National Blood Clot Alliance

Other Stakeholder Partners

  • No information provided by awardee.
Page Last Updated: 
December 8, 2020

Research & Results

  • Explore Our Portfolio
  • Research Fundamentals
  • Research Results Highlights
  • Putting Evidence to Work
  • Peer Review
  • Evidence Synthesis
  • About Our Research

About Us

  • Our Programs
  • Governance
  • Financials and Reports
  • Procurement Opportunities
  • Our Staff
  • Our Vision & Mission
  • Contact Us

Research & Results

  • Explore Our Portfolio
  • Research Fundamentals
  • Research Results Highlights
  • Putting Evidence to Work
  • Peer Review
  • Evidence Synthesis
  • About Our Research

Engagement

  • The Value of Engagement
  • Engagement in Health Research Literature Explorer
  • Influencing the Culture of Research
  • Engagement Awards
  • Engagement Resources
  • Engage with Us

Funding Opportunities

  • What & Who We Fund
  • What You Need to Know to Apply
  • Applicant Training
  • Merit Review
  • Awardee Resources
  • Help Center

Meetings & Events

February 2
PCORI 2021 and Beyond: Opportunities for Funding and Involvement in Patient-Centered Research
February 9
Board of Governors Meeting: February 9, 2021
February 11
Advisory Panel on Patient Engagement Winter 2021 Meeting

PCORI

Footer contact address

Patient-Centered Outcomes
Research Institute

1828 L Street, NW, Suite 900
Washington, DC 20036
Phone: (202) 827-7700 | Fax: (202) 355-9558
[email protected]

Subscribe to Newsletter

Twitter Facebook LinkedIn Vimeo

© 2011-2021 Patient-Centered Outcomes Research Institute. All Rights Reserved.

Privacy Policy | Terms of Use | Trademark Usage Guidelines | Credits | Help Center